Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide in Autistic Children (BUMEA)
NCT01078714Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Mar 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bumetanide in Autism Spectrum Disorder (ASD), sponsored by Centre Hospitalier Universitaire de Brest. Started Mar 2010; status: completed.
02
Drugs
bumetanide
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01078714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01078714.